Clinical Trial Update: Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates how different clopidogrel doses influence platelet inhibition in patients with chronic kidney disease and stable angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Stable Angina

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Chronic Kidney Disease, Stable Angina | Phase 4 | Status: COMPLETED